annual cash & cash equivalents:
$2.41B+$906.55M(+60.18%)Summary
- As of today (May 20, 2025), JAZZ annual cash & cash equivalents is $2.41 billion, with the most recent change of +$906.55 million (+60.18%) on December 31, 2024.
- During the last 3 years, JAZZ annual cash & cash equivalents has risen by +$1.82 billion (+307.96%).
- JAZZ annual cash & cash equivalents is now at all-time high.
Performance
JAZZ Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$1.86B-$550.92M(-22.83%)Summary
- As of today (May 20, 2025), JAZZ quarterly cash & cash equivalents is $1.86 billion, with the most recent change of -$550.92 million (-22.83%) on March 1, 2025.
- Over the past year, JAZZ quarterly cash & cash equivalents has increased by +$418.56 million (+29.00%).
- JAZZ quarterly cash & cash equivalents is now -22.83% below its all-time high of $2.41 billion, reached on December 31, 2024.
Performance
JAZZ quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
JAZZ Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +60.2% | +29.0% |
| 3 y3 years | +308.0% | +279.3% |
| 5 y5 years | +278.6% | +165.4% |
JAZZ Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +308.0% | -22.8% | +279.3% |
| 5 y | 5-year | at high | +308.0% | -22.8% | +279.3% |
| alltime | all time | at high | >+9999.0% | -22.8% | >+9999.0% |
JAZZ Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $1.86B(-22.8%) |
| Dec 2024 | $2.41B(+60.2%) | $2.41B(+8.8%) |
| Sep 2024 | - | $2.22B(+63.6%) |
| Jun 2024 | - | $1.36B(-6.1%) |
| Mar 2024 | - | $1.44B(-4.2%) |
| Dec 2023 | $1.51B(+70.9%) | $1.51B(+12.8%) |
| Sep 2023 | - | $1.34B(+4.2%) |
| Jun 2023 | - | $1.28B(+9.8%) |
| Mar 2023 | - | $1.17B(+32.5%) |
| Dec 2022 | $881.48M(+49.0%) | $881.48M(+5.0%) |
| Sep 2022 | - | $839.36M(+18.0%) |
| Jun 2022 | - | $711.26M(+44.9%) |
| Mar 2022 | - | $490.83M(-17.0%) |
| Dec 2021 | $591.45M(-44.1%) | $591.45M(-12.0%) |
| Sep 2021 | - | $671.78M(-24.6%) |
| Jun 2021 | - | $891.40M(-57.5%) |
| Mar 2021 | - | $2.10B(+98.3%) |
| Dec 2020 | $1.06B(+66.0%) | $1.06B(+42.6%) |
| Sep 2020 | - | $741.94M(-5.6%) |
| Jun 2020 | - | $786.08M(+12.0%) |
| Mar 2020 | - | $701.60M(+10.1%) |
| Dec 2019 | $637.34M(+105.8%) | $637.34M(-19.8%) |
| Sep 2019 | - | $795.17M(+24.7%) |
| Jun 2019 | - | $637.74M(+16.5%) |
| Mar 2019 | - | $547.47M(+76.8%) |
| Dec 2018 | $309.62M(-19.8%) | $309.62M(-38.0%) |
| Sep 2018 | - | $499.02M(+2.9%) |
| Jun 2018 | - | $485.08M(+7.0%) |
| Mar 2018 | - | $453.17M(+17.4%) |
| Dec 2017 | $386.04M(+5.5%) | $386.04M(+52.8%) |
| Sep 2017 | - | $252.62M(+5.6%) |
| Jun 2017 | - | $239.21M(-31.1%) |
| Mar 2017 | - | $347.00M(-5.2%) |
| Dec 2016 | $365.96M(-63.0%) | $365.96M(-0.2%) |
| Sep 2016 | - | $366.57M(-57.8%) |
| Jun 2016 | - | $867.97M(-11.4%) |
| Mar 2016 | - | $979.78M(-0.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2015 | $988.78M(+44.6%) | $988.78M(-1.0%) |
| Sep 2015 | - | $998.86M(+8.4%) |
| Jun 2015 | - | $921.64M(+17.8%) |
| Mar 2015 | - | $782.60M(+14.4%) |
| Dec 2014 | $684.04M(+7.5%) | $684.04M(+19.0%) |
| Sep 2014 | - | $575.04M(+114.4%) |
| Jun 2014 | - | $268.25M(+9.1%) |
| Mar 2014 | - | $245.87M(-61.4%) |
| Dec 2013 | $636.50M(+64.4%) | $636.50M(+8.2%) |
| Sep 2013 | - | $588.46M(+16.7%) |
| Jun 2013 | - | $504.31M(+11.9%) |
| Mar 2013 | - | $450.51M(+16.4%) |
| Dec 2012 | $387.20M(+371.8%) | $387.20M(+104.0%) |
| Sep 2012 | - | $189.79M(+22.8%) |
| Jun 2012 | - | $154.54M(-9.4%) |
| Mar 2012 | - | $170.65M(+107.9%) |
| Dec 2011 | $82.08M(+83.2%) | $82.08M(-18.9%) |
| Sep 2011 | - | $101.22M(-1.2%) |
| Jun 2011 | - | $102.40M(+57.4%) |
| Mar 2011 | - | $65.06M(+45.2%) |
| Dec 2010 | $44.79M(+187.2%) | $44.79M(+367.9%) |
| Jun 2010 | - | $9.57M(-49.6%) |
| Mar 2010 | - | $19.00M(+21.8%) |
| Dec 2009 | $15.60M(-37.4%) | $15.60M(+27.5%) |
| Sep 2009 | - | $12.23M(-22.5%) |
| Jun 2009 | - | $15.77M(-7.3%) |
| Mar 2009 | - | $17.02M(-31.7%) |
| Dec 2008 | $24.90M(-75.8%) | $24.90M(-50.1%) |
| Sep 2008 | - | $49.91M(-2.5%) |
| Jun 2008 | - | $51.20M(-49.2%) |
| Mar 2008 | - | $100.77M(-2.1%) |
| Dec 2007 | $102.94M(+30.4%) | $102.94M(-14.2%) |
| Sep 2007 | - | $119.97M(-18.9%) |
| Jun 2007 | - | $148.00M(+118.7%) |
| Mar 2007 | - | $67.67M(-14.3%) |
| Dec 2006 | $78.95M(+283.0%) | $78.95M(+283.0%) |
| Dec 2005 | $20.61M | $20.61M |
FAQ
- What is Jazz Pharmaceuticals annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Jazz Pharmaceuticals?
- What is Jazz Pharmaceuticals annual cash & cash equivalents year-on-year change?
- What is Jazz Pharmaceuticals quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for Jazz Pharmaceuticals?
- What is Jazz Pharmaceuticals quarterly cash & cash equivalents year-on-year change?
What is Jazz Pharmaceuticals annual cash & cash equivalents?
The current annual cash & cash equivalents of JAZZ is $2.41B
What is the all time high annual cash & cash equivalents for Jazz Pharmaceuticals?
Jazz Pharmaceuticals all-time high annual cash & cash equivalents is $2.41B
What is Jazz Pharmaceuticals annual cash & cash equivalents year-on-year change?
Over the past year, JAZZ annual cash & cash equivalents has changed by +$906.55M (+60.18%)
What is Jazz Pharmaceuticals quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of JAZZ is $1.86B
What is the all time high quarterly cash & cash equivalents for Jazz Pharmaceuticals?
Jazz Pharmaceuticals all-time high quarterly cash & cash equivalents is $2.41B
What is Jazz Pharmaceuticals quarterly cash & cash equivalents year-on-year change?
Over the past year, JAZZ quarterly cash & cash equivalents has changed by +$418.56M (+29.00%)